Methadone maintenance treatment and mortality in HIV-positive people who inject opioids in China

OBJECTIVE: To examine the effect of methadone maintenance treatment (MMT) on mortality in people injecting opioids who receive antiretroviral therapy (ART) for the treatment of human immunodeficiency virus (HIV) infection in China. METHODS: The study involved a nationwide cohort of 23 813 HIV-positi...

Full description

Bibliographic Details
Main Authors: Yan Zhao, Cynthia X Shi, Jennifer M McGoogan, Keming Rou, Fujie Zhang, Zunyou Wu
Format: Article
Language:English
Published: The World Health Organization
Series:Bulletin of the World Health Organization
Online Access:http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862013000200009&lng=en&tlng=en
_version_ 1827337487182200832
author Yan Zhao
Cynthia X Shi
Jennifer M McGoogan
Keming Rou
Fujie Zhang
Zunyou Wu
author_facet Yan Zhao
Cynthia X Shi
Jennifer M McGoogan
Keming Rou
Fujie Zhang
Zunyou Wu
author_sort Yan Zhao
collection DOAJ
description OBJECTIVE: To examine the effect of methadone maintenance treatment (MMT) on mortality in people injecting opioids who receive antiretroviral therapy (ART) for the treatment of human immunodeficiency virus (HIV) infection in China. METHODS: The study involved a nationwide cohort of 23 813 HIV-positive (HIV+) people injecting opioids who received ART between 31 December 2002 and 31 December 2011. Mortality rates and demographic, disease and treatment characteristics were compared in patients who received either ART and MMT or ART only. Factors associated with mortality were identified by univariate and multivariate analysis. FINDINGS: Overall, 3057 deaths occurred during 41 959 person-years of follow-up (mortality: 7.3 per 100 person-years; 95% confidence interval, CI: 7.0-7.5). Mortality 6 months after starting ART was significantly lower with ART and MMT than with ART only (6.6 versus 16.9 per 100 person-years, respectively; P < 0.001). After 12 months, mortality was 3.7 and 7.4 per 100 person-years in the two groups, respectively (P < 0.001). Not having received MMT was an independent predictor of death (adjusted hazard ratio: 1.4; 95% CI: 1.3-1.6). Other predictors were a low haemoglobin level and a low CD4+ T-lymphocyte count at ART initiation and treatment at facilities other than infectious disease hospitals. CONCLUSION: Patients would benefit more from both MMT and HIV treatment programmes and would face fewer barriers to care if cross-referrals between programmes were promoted and ART and MMT services were located together.
first_indexed 2024-03-07T18:55:45Z
format Article
id doaj.art-d93de38e42a946fa99c6ebbbeaa6509a
institution Directory Open Access Journal
issn 0042-9686
language English
last_indexed 2024-03-07T18:55:45Z
publisher The World Health Organization
record_format Article
series Bulletin of the World Health Organization
spelling doaj.art-d93de38e42a946fa99c6ebbbeaa6509a2024-03-02T00:28:00ZengThe World Health OrganizationBulletin of the World Health Organization0042-96869129310110.2471/BLT.12.108944S0042-96862013000200009Methadone maintenance treatment and mortality in HIV-positive people who inject opioids in ChinaYan Zhao0Cynthia X Shi1Jennifer M McGoogan2Keming Rou3Fujie Zhang4Zunyou Wu5Chinese Center for Disease Control and PreventionChinese Center for Disease Control and PreventionChinese Center for Disease Control and PreventionChinese Center for Disease Control and PreventionChinese Center for Disease Control and PreventionChinese Center for Disease Control and PreventionOBJECTIVE: To examine the effect of methadone maintenance treatment (MMT) on mortality in people injecting opioids who receive antiretroviral therapy (ART) for the treatment of human immunodeficiency virus (HIV) infection in China. METHODS: The study involved a nationwide cohort of 23 813 HIV-positive (HIV+) people injecting opioids who received ART between 31 December 2002 and 31 December 2011. Mortality rates and demographic, disease and treatment characteristics were compared in patients who received either ART and MMT or ART only. Factors associated with mortality were identified by univariate and multivariate analysis. FINDINGS: Overall, 3057 deaths occurred during 41 959 person-years of follow-up (mortality: 7.3 per 100 person-years; 95% confidence interval, CI: 7.0-7.5). Mortality 6 months after starting ART was significantly lower with ART and MMT than with ART only (6.6 versus 16.9 per 100 person-years, respectively; P < 0.001). After 12 months, mortality was 3.7 and 7.4 per 100 person-years in the two groups, respectively (P < 0.001). Not having received MMT was an independent predictor of death (adjusted hazard ratio: 1.4; 95% CI: 1.3-1.6). Other predictors were a low haemoglobin level and a low CD4+ T-lymphocyte count at ART initiation and treatment at facilities other than infectious disease hospitals. CONCLUSION: Patients would benefit more from both MMT and HIV treatment programmes and would face fewer barriers to care if cross-referrals between programmes were promoted and ART and MMT services were located together.http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862013000200009&lng=en&tlng=en
spellingShingle Yan Zhao
Cynthia X Shi
Jennifer M McGoogan
Keming Rou
Fujie Zhang
Zunyou Wu
Methadone maintenance treatment and mortality in HIV-positive people who inject opioids in China
Bulletin of the World Health Organization
title Methadone maintenance treatment and mortality in HIV-positive people who inject opioids in China
title_full Methadone maintenance treatment and mortality in HIV-positive people who inject opioids in China
title_fullStr Methadone maintenance treatment and mortality in HIV-positive people who inject opioids in China
title_full_unstemmed Methadone maintenance treatment and mortality in HIV-positive people who inject opioids in China
title_short Methadone maintenance treatment and mortality in HIV-positive people who inject opioids in China
title_sort methadone maintenance treatment and mortality in hiv positive people who inject opioids in china
url http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862013000200009&lng=en&tlng=en
work_keys_str_mv AT yanzhao methadonemaintenancetreatmentandmortalityinhivpositivepeoplewhoinjectopioidsinchina
AT cynthiaxshi methadonemaintenancetreatmentandmortalityinhivpositivepeoplewhoinjectopioidsinchina
AT jennifermmcgoogan methadonemaintenancetreatmentandmortalityinhivpositivepeoplewhoinjectopioidsinchina
AT kemingrou methadonemaintenancetreatmentandmortalityinhivpositivepeoplewhoinjectopioidsinchina
AT fujiezhang methadonemaintenancetreatmentandmortalityinhivpositivepeoplewhoinjectopioidsinchina
AT zunyouwu methadonemaintenancetreatmentandmortalityinhivpositivepeoplewhoinjectopioidsinchina